| Abscess..................................................................................55 |
| Actinomyces........................................................................102 |
| Age-related macular degeneration.........................................84 |
| Amblyopia...........................................................................310 |
| Amniotic membrane transplantation...................................356 |
| Amsler-Krumeich................................................................117 |
| Angle surgery......................................................................347 |
| Aniridia-related glaucoma...................................................183 |
| Anisometropia.....................................................................310 |
| Ankylosing spondylitis..........................................................10 |
| Anterior uveitis......................................................................99 |
| Anti-vascular endothelial growth factor........................30, 258 |
| Antidepressant drug................................................................1 |
| Aphakia...............................................................................277 |
| Argus II...............................................................................213 |
| Artificial vision....................................................................213 |
| Assessment of residual functional vision................................89 |
| Assessment of residual visual functions.................................89 |
| Balance................................................................................243 |
| Behçet’s disease......................................................................40 |
| Best disease |
| Bietti crystalline dystrophy.................................................106 |
| Bionic eye............................................................................213 |
| Body position..........................................................................6 |
| Breast cancer........................................................................171 |
| Breast carcinoma..................................................................168 |
| C3F8....................................................................................201 |
| Canaliculitis.........................................................................102 |
| Cancer..................................................................................305 |
| Candida endophthalmitis....................................................294 |
| Cannabinoid........................................................................114 |
| Cataract................................................................................243 |
| Cataract surgery.....................................................................15 |
| Central serous chorioretinopathy.....................................30, 40 |
| Central serous chorioretinopathy like maculopathy.............367 |
| Children...............................................................................283 |
| Choroidal folds....................................................................367 |
| Choroidal thickness...............................................................20 |
| Chronic macular edema.......................................................315 |
| Clinical retinal detachment.................................................342 |
| Colistin................................................................................220 |
| Complicated inferior retinal detachment.............................334 |
| Congenital aniridia..............................................................183 |
| Congenital cataract................................................................25 |
| Congenital toxoplasmosis....................................................230 |
| Cornea....................................................................................55 |
| Corneal calcification.............................................................123 |
| Corneal endothelial cell density...........................................178 |
| Corneal endothelial function................................................178 |
| Corticosteroid......................................................................367 |
| Cryotherapy.........................................................................364 |
| Cumulative..........................................................................149 |
| Curettage.............................................................................102 |
| Current approaches..............................................................154 |
| Cystic changes.....................................................................194 |
| Cystoid macular degeneration.............................................315 |
| Cystoid macular edema........................................................297 |
| Dacryocystitis......................................................................164 |
| Demography..........................................................................10 |
| Dengue maculopathy.............................................................51 |
| Densiron®......................................................................68, 334 |
| Depression...............................................................................1 |
| Dexamethasone......................................................................73 |
| Dexamethasone implant..............................................250, 323 |
| Diabetic macular edema...............................73, 194, 315, 323 |
| Diabetic macular ischemia...................................................194 |
| Diabetic retinopathy............................................................315 |
| Diagnostic vitrectomy...........................................................44 |
| DMEK.................................................................................235 |
| DMÖ...................................................................................323 |
| Dose.....................................................................................149 |
| Dry eye........................................................................142, 356 |
| Dynamic pupillometry........................................................310 |
| En face optical coherence tomography...................................84 |
| Endocarditis.........................................................................361 |
| Endogenous endophthalmitis..............................................294 |
| Endophthalmitis..................................................................361 |
| Endoscopic surgeries..............................................................47 |
| Etiology.................................................................................10 |
| Exenteration........................................................................305 |
| Exogenous endophthalmitis..................................................44 |
| Extraocular muscle...............................................................168 |
| Extrapulmonary tuberculosis...............................................188 |
| Eye.........................................................................................78 |
| Eye drops.............................................................................123 |
| Eye screening.........................................................................25 |
| Eyelid..................................................................................224 |
| Falls.....................................................................................243 |
| First-line treatment.............................................................342 |
| Fuchs’ endothelial dystrophy...............................................235 |
| Fundus autofluorescence......................................................149 |
| Ganglion cell complex.........................................................134 |
| Genetics...............................................................................347 |
| Glaucoma.............................................61, 130, 134, 183, 283 |
| Glaucoma drainage devices..................................................183 |
| Glaucoma drainage implants...............................................347 |
| Gout....................................................................................178 |
| High-density silicone oils....................................................334 |
| HLA-B27..............................................................................10 |
| Hydroxychloroquine............................................................149 |
| Icare.....................................................................................130 |
| Idiopathic macular hole.......................................................328 |
| Imaging modalities..............................................................300 |
| Immunohistochemistry..........................................................68 |
| Individualized medicine......................................................258 |
| Intermediate uveitis.............................................................297 |
| Intraocular lens dislocation..................................................277 |
| Intraocular pressure.........................................................6, 130 |
| Intravitreal dexamethasone implant....................................175 |
| Intravitreal injection............................................................250 |
| Iris-claw lens........................................................................277 |
| Keratitis...............................................................................220 |
| Laser photocoagulation........................................................342 |
| Lattice degeneration............................................................209 |
| Lecturers..............................................................................142 |
| Lithotripsy...........................................................................294 |
| Low vision.....................................................................89, 154 |
| Low vision aids......................................................................89 |
| Low vision rehabilitation...............................................89, 154 |
| LVA......................................................................................154 |
| Macular hole................................................................201, 209 |
| Maculopathy........................................................................149 |
| Medial rectus muscle...........................................................168 |
| Melanoma............................................................................305 |
| Microvascular changes.........................................................300 |
| Multiple drug-resistant pseudomonas aeruginosa................220 |
| Multiple sclerosis.................................................................364 |
| Nasolacrimal duct obstruction.............................................164 |
| Negative performance............................................................25 |
| Neovascular age-related macular degeneration..............15, 258 |
| Neurofibroma......................................................................224 |
| Obstructive sleep apnea syndrome.......................................134 |
| Ocular hypertension............................................................134 |
| Ocular inflammation...........................................................188 |
| Ocular metastasis.................................................................171 |
| Ocular surface......................................................................356 |
| Ocular surface disease index................................................142 |
| Ocular toxoplasmosis...........................................................230 |
| Ocular trauma.......................................................................44 |
| Optic disc............................................................................134 |
| Optic disc drusen.................................................................300 |
| Optic nerve head infiltration |
| Optical coherence................................................................315 |
| Optical coherence tomography.....................78, 106, 109, 194 |
| Optical coherence tomography angiography......106, 226, 300 |
| Orbital metastasis........................................................168, 305 |
| OSDI...................................................................................142 |
| Osmolarity...........................................................................123 |
| Outer retinal degeneration..................................................213 |
| Outer retinal microhole.......................................................109 |
| Oxane® HD.........................................................................334 |
| Oxidative stress......................................................................61 |
| Oxytocin................................................................................68 |
| Ozurdex...............................................................................175 |
| Ozurdex...............................................................................250 |
| Pachychoroid neovasculopathy............................................226 |
| Pars plana vitrectomy.................................230, 270, 323, 328 |
| Penetrating keratoplasty................................................55, 270 |
| Penetration trauma................................................................44 |
| Pericarditis...........................................................................361 |
| Periorbital emphysema..........................................................47 |
| Peripheral ischemia..............................................................194 |
| Phacoemulsification.............................................................243 |
| Phosphate....................................................................123, 213 |
| Pneumatic displacement........................................................51 |
| Pneumatic vitreolysis...........................................................201 |
| Polymerase chain reaction (PCR).........................................361 |
| Presumed ocular tuberculosis |
| Primary congenital glaucoma..............................................347 |
| Proliferative.........................................................................334 |
| Pseudoexfoliation...............................................................1, 61 |
| Pseudopapilledema..............................................................300 |
| Pseudophakic bullous keratopathy......................................235 |
| Punctoplasty........................................................................102 |
| Pupillary light reflex...........................................................310 |
| Purtscher-like retinopathy...................................................114 |
| Quiescent type 1 choroidal neovascularization......................84 |
| Ranibizumab...................................................................15, 73 |
| Red reflex test........................................................................25 |
| Relapsing polychondritis.......................................................99 |
| Retina....................................................................................78 |
| Retinal dystrophy................................................................106 |
| Retinal hole.................................................................175, 209 |
| Retinal prosthesis................................................................213 |
| Retinal tear..........................................................................209 |
| Retinal thickness...................................................................20 |
| Retinitis pigmentosa...........................................................213 |
| Retinoblastoma......................................................................25 |
| Retinopathy...........................................................................68 |
| Retinopathy of prematurity.................................................230 |
| Rheumatoid arthritis...........................................................367 |
| Scheimpflug camera.............................................................117 |
| Secondary lens implantation................................................277 |
| SF6.......................................................................................201 |
| Smoking................................................................................20 |
| Spectral domain optical coherence tomography...............20, 84 |
| Specular microscopy............................................................178 |
| Staphylococcus epidermidis...................................................44 |
| Steroid...................................................................................40 |
| Strabismus...........................................................................310 |
| Streptozotocin........................................................................68 |
| Sub-ILM hemorrhage............................................................51 |
| Subclinical retinal detachment............................................342 |
| Substance abuse...................................................................114 |
| Subthreshold micropulse laser...............................................30 |
| Syphilis................................................................................297 |
| Systemic autoimmune disease................................................99 |
| Tarsus..................................................................................224 |
| Temporary keratoprosthesis.................................................270 |
| Therapeutics..........................................................................55 |
| Tomography........................................................................315 |
| Tonometer...............................................................................6 |
| Tonometry...........................................................................130 |
| Toxic epidermal necrolysis...................................................356 |
| Toxoplasma gondii..............................................................230 |
| Treat and extend dosing......................................................258 |
| Tuberculosis.........................................................................188 |
| Tuberculosis.........................................................................361 |
| Tularemia............................................................................164 |
| Tumor..................................................................................224 |
| Unilateral keratoconus.........................................................117 |
| Ureteral stone......................................................................294 |
| Uveitis......................................................... 10, 250, 283, 364 |
| Valsalva maneuver.................................................................47 |
| Vascular endothelial growth factor........................................73 |
| Vasoproliferative tumor.......................................................364 |
| VEGF....................................................................................68 |
| Verteporfin photodynamic therapy........................................30 |
| Vision..................................................................................243 |
| Visual prosthesis..................................................................213 |
| Vitrectomy..........................................................................277 |
| Vitrectomy under air...........................................................328 |
| Vitreomacular traction.........................................................109 |
| Vitreomacular traction.........................................................201 |
| Vitreoretinopathy................................................................334 |